Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Baxter
Dow
McKinsey
Harvard Business School

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lemborexant

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Lemborexant?

Lemborexant is an investigational drug.

There have been 12 clinical trials for Lemborexant. The most recent clinical trial was a Phase 1 trial, which was initiated on July 15th 2019.

The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Disease, and Liver Diseases. The leading clinical trial sponsors are Eisai Inc., Purdue Pharma LP, and [disabled in preview].

There are four US patents protecting this investigational drug and fifty-nine international patents.

Recent Clinical Trials for Lemborexant
TitleSponsorPhase
A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of InsomniaEisai Inc.Phase 3
Study of Lemborexant-Alcohol Interaction in Healthy SubjectsPurdue Pharma LPPhase 1
Study of Lemborexant-Alcohol Interaction in Healthy SubjectsEisai Inc.Phase 1

See all Lemborexant clinical trials

Clinical Trial Summary for Lemborexant

Top disease conditions for Lemborexant
Top clinical trial sponsors for Lemborexant

See all Lemborexant clinical trials

US Patents for Lemborexant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lemborexant   Start Trial Compositions and methods for treating insomnia Eisai R&D Management Co., Ltd. (Tokyo, JP)   Start Trial
Lemborexant   Start Trial Cyclopropane compound Eisai R&D Management Co., Ltd. (Tokyo, JP)   Start Trial
Lemborexant   Start Trial Methods and compounds useful in the synthesis of orexin-2 receptor antagonists Eisai R&D Management Co., Ltd. (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Moodys
Boehringer Ingelheim
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.